Disclosure Of Fair Value Measurement [Text Block]

Sopharma Trading AD - Filing #6022483

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
643 151 BGN
572 554 BGN
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
520 045 BGN
478 009 BGN
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
123 106 BGN
9 658 BGN
163,000 BGN
70 329 BGN
34 276 BGN
876,000 BGN
27 120 BGN
25 436 BGN
94 545 BGN
225,000 BGN
55 181 BGN
21 441 BGN
34 276 BGN
868,000 BGN
25 773 BGN
225,000 BGN
24 912 BGN
50 463 BGN
84 900 BGN
797,000 BGN
34 276 BGN
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.